CEO of healthcare start-up describes challenging times for venture funding

What’s the future like for healthcare companies when it comes to venture investment? Eric Stone, Co-Founder and Chief Executive Officer of Velano Vascular, writes the following in a publication named STAT: “New deals are exceedingly rare right now, and industry pundits say that the deals that do get done are on far less frothy, or certainly more realistic, terms — approximately 30 percent lower valuations and falling — than before COVID-19.” He continues: “The word on the street is that venture capital firms are looking for a two-year runway, a difficult measure to assess in times of extreme uncertainty.” Click here for the full article.

Stay connected with us on Twitter and LinkedIn. Article ideas and other suggestions should be sent to Include the name and contact information (phone and email) for follow-up.